A New England Journal of Medicine study published yesterday found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer patients instead of traditional methods such as chemotherapy, radiation or surgery. All 49 patients of the first cohort, who had rectal cancer, had their cancer disappear and continued treatment with nonoperative management. The second cohort of patients had other cancers, and 35 of 54 in that group had their cancer eradicated. Thirty-three continued with nonoperative treatment. 

Related News Articles

Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services Aug. 21 announced the creation of a Healthcare Advisory…
Headline
The American Heart Association and American College of Cardiology Aug. 14 released new guidelines on high blood pressure prevention, suggesting earlier…
Headline
Josh Neff, CEO of CommonSpirit Mercy Hospital, discusses a new cutting-edge communication platform that sends patient EKGs directly from the ambulance to the…
Headline
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal cancer, a finding that coincides with recommendations by…
Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…